O

Organon & Co
D

OGN

15.490
USD
-0.18
(-1.12%)
مغلق
حجم التداول
144,037
الربح لكل سهم
7
العائد الربحي
7.23
P/E
3
حجم السوق
3,989,277,174
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
الأخبار
المقالات

العنوان: Organon & Co

القطاع: Healthcare
الصناعة: Drug Manufacturers - General
Organon & Co is a science-based global pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's operations include the following product portfolio: Women's health, Biosimilars, and Established medicines. Geographically, it derives a majority of its revenue from Europe and Canada followed by the United States and then Asia Pacific and Japan. The company generates the majority of its revenue from the Established Brands product portfolio.